Dr. Klára Gadó

College Professor


Tel.: 00 36 1 486 5970
E-mail: gado.klara@semmelweis.hu

Education and training:

  • SOTE Faculty of Medicine clinical pharmacologist
  • internal medicine
  • clinical immunologist
  • hematologist

Scientific degree(s):

PhD, Topic of PhD doctoral dissertation: The role of prolactin in multiple myeloma

Professional-scientific career:

  • EGIS Pharmaceuticals, research pharmacologist
  • HIETE, Department of Internal Medicine I
  • National Institute of Hematology and Blood Transfusion
  • St. Rokus Hospital, Department of Immunology, Internal Medicine I – Chief Physician
  • currently: St. Rokus Hospital, Department of Internal Medicine Rehabilitation – Chief Physician
  • currently: Semmelweis University, Faculty of Health Sciences, Department of Clinical Studies – College professor.

Subjects taught:

Fundamentals of clinical sciences

Internal medicine

The 5 most important recent publications:

  • Kadó K.: Our expanding knowledge about the genetic background of a malignant hematopoietic organ disease, multiple myeloma. Magyar Tudomány, 2010; 171 (5) 558-562.
  • Gadó K, Demeter J, Várnai K, Kicsi D, Nagy Zs, Bek õ G, Sátori A, Domján Gy .: Investigation of blood coagulation in multiple myeloma. Magyar Belorvosi Archívum, 2010; 63 (5) 322-325.
  • Losonczy H, Tar A, Domján Gy, Gadó K, Gyáni É, Szalisznyó I, Kecskés G, Wrana G, Lakatos J, Barber C, Ledniczki I, Al-Absi S, Mayer K, Jójárt I, Ruzsa C, Bernáth B , Zeher M, Kerekes G: Results of the ENDORSE study in Hungary: International cross-sectional survey of the risk and prophylaxis of venous thromboembolism in acute hospital patients. Orvosi Hetilap, 2008; 149 (44) 2069-2076
  • Gadó K; Small D; Menyhart O; Konyar E; Domjan Gy. Plasmocytomas of the skull base – three case reports. Blood Reviews, 2007; 21 128-S128.
  • Gadó K. Myelodysplasia syndromes: new therapeutic options. 2007; 17 (12) 43-851

The 5 most important publications / scientific results closely related to professional interest:

  • Gadó K, Domján G, Kormos L, Falus A.: Functional significance of genetic abnormalities in multiple myeloma. Hematology, 2002; 32 (3): 191-208
  • Gadó K, Nagy G, Hasitz A, Toth BE, Rimanoczi E, Domjan G. Evidence of prolactin immunoreactivity in the bone marrow of untreated multiple myeloma patients. Neuroimmunomodulation, 2001; 9 (2) 95-102.
  • Gadó K, Pallinger E, Kovacs P, Takacs E, Szilvasi I, Toth BE, Nagy G, Domjan G, Falus A .: Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266. Immunology Letters, 2002; 82 (3) 91-6.
  • Gadó K, Rimanoczi E, Hasitz A, Gigler G, Toth BE, Nagy GM, Paloczi K, Domjan Gy .: Elevated levels of serum prolactin in patients with advanced multiple myeloma. Neuroimmunomodulation, 2001; 9 (4): 231-6.
  • Gadó K, Silva S, Paloczi K, Domjan G, Falus A .: Mouse plasmacytoma: an experimental model of human multiple myeloma. Haematologica, 2001; 86 (3) 227-36.

Public activity:

  • Hungarian Society of Internal Medicine
  • Hungarian Society of Thrombosis and Hemostasis
  • Hungarian Hematology and Blood Transfusion Society

Participation in doctoral training:

Opponent: Semmelweis University, Fundamentals of Human Molecular Genetics and Genetic Diagnostics

Participation in TDK work:

Supervisor of 2 TDK works